skip to primary navigationskip to content

Nobel-winning drug 'tackles malaria'.

last modified Oct 28, 2015 10:11 AM
Early data coming out of trials of ivermectin in Burkina Faso suggest it leads to 16% fewer cases of childhood malaria.

Scientists at the American Society of Tropical Medicine and Hygiene's conference, said the drug was toxic to blood-drinking mosquitoes.

They said their findings were pretty exciting, but still at an early stage.

Ivermectin is already used to kill parasitic worms, which affect a third of the world's population and cause illnesses including river blindness and lymphatic filariasis.

Its discovery won this year's Nobel Prize for Physiology or Medicine.

More can be read on the BBC health website http://www.bbc.co.uk/news/health-34649016

Upcoming events

Your personal immune army

Mar 26, 2017

Cambridge Biomedical Campus, UTC Cambridge Robinson Way Cambridge CB2 0SZ, CB2 0SZ

The Ageing Cell Conference 2017

Mar 27, 2017

The Babraham Institute

Cells as Models of Disease and New Therapeutics

Mar 29, 2017

Homerton College, in Cambridge,

Cambridge Immunology PhD and Postdoc Day 2017

Jun 08, 2017

Cancer Research UK, Cambridge Institute

Upcoming events

FCEs provide interdisciplinary training programmes for students, fellows and continuing education physicians through FOCIS assisted opportunities

Read more